Aiming to create a biosensor that can detect Sars-Cov-2 spike protein in patient's samples as a way to facilitate the diagnosis of COVID19 in the state of Amazonas.
Combinação SynBio e o artigo que estamos usando como base:
[ ] Expressão de ACE2 em bactéria (qual abordagem utilizar?)
[ ] Quais plasmídeos utilizar?
[ ] Qual cepa fazer a transfecção?
[ ] ACE2 fusionada com Fc;
[ ] Purificação e SDS-PAGE da ACE2;
[ ] Contrução do teste:
pCL2 as N-terminal fusions to Aga2p followed by eGFP;
[ ] Miniprep;
[ ] Screening:
cells were washed twice with PBSA and stained with 50 nM biotinylated RBD monomer (10 ml) for 1 hour at room temperature
[ ] Citometria de Fluxo;
To fit yeast binding data to KD values, Alexa Fluor 647 mean fluorescence intensities were extracted from the GFP-positive population, background subtracted using secondary only controls, normalized to the highest fluorescent population, and fit to the Hill equation without cooperativity in Python.
[ ] In vitro binding and activity characterization of inactivation mutations in ACE2-Fc;
[ ] Pseudotyped SARS-CoV-2 neutralization IC50 curves for WT and engineered ACE2(614)-Fc and ACE2(740)-Fc molecules.
[ ] Live virus qPCR assays of three viral genes (N, E, RdRp) were run 16 hours post-infection using host genes BGUS or ACTB as normalization controls.
Combinação SynBio e o artigo que estamos usando como base:
[ ] Expressão de ACE2 em bactéria (qual abordagem utilizar?)
[ ] Quais plasmídeos utilizar?
[ ] Qual cepa fazer a transfecção?
[ ] ACE2 fusionada com Fc;
[ ] Purificação e SDS-PAGE da ACE2;
[ ] Contrução do teste: pCL2 as N-terminal fusions to Aga2p followed by eGFP;
[ ] Miniprep;
[ ] Screening:
[ ] In vitro binding and activity characterization of inactivation mutations in ACE2-Fc;
[ ] Pseudotyped SARS-CoV-2 neutralization IC50 curves for WT and engineered ACE2(614)-Fc and ACE2(740)-Fc molecules.
[ ] Live virus qPCR assays of three viral genes (N, E, RdRp) were run 16 hours post-infection using host genes BGUS or ACTB as normalization controls.